I'm not doubting every step they are taking. I'm trying to believe the company when they tell me that Plexus is responsible for deal origination for the rest of the world outside of China.
So what you are saying is this is incorrect and deal interest originated to date in South America and MENA has somehow been originated by PAR itself? Because Plexus has no interest dealing in these markets.
Now we have Scott Williams with ZERO experience in biotech deal negotiations bringing our regional deals home. Great, thanks for clarifying.
I'm not doubting every step they are taking. I'm trying to...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
0.005(1.89%) |
Mkt cap ! $92.69M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.0¢ | 27.0¢ | $2.025K | 7.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1924 | 26.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 52452 | 3 |
View Market Depth
| Last trade - 10.06am 28/05/2024 (20 minute delay) ? |
|
|||||
|
Last
26.5¢ |
Change
0.005 ( 1.92 %) |
||||
| Open | High | Low | Volume | ||
| 26.0¢ | 26.5¢ | 26.0¢ | 36549 | ||
| Last updated 10.26am 28/05/2024 ? | |||||
| PAR (ASX) Chart |